Pars plana vitrectomy for vitreo-retinal complications of birdshot chorioretinopathy.
To evaluate the anatomical and functional outcomes of pars plana vitrectomy (PPV) in the treatment of vitreoretinal complications of birdshot chorioretinopathy (BCR). The clinical records of 9 consecutive patients (16 eyes) with vitreo retinal complications in BCR refractory to medical therapy who underwent pars plana vitrectomy were reviewed. Indications for PPV were macular edema in 9 eyes (56.2%), and persistent vitreous opacities in 7 (43.8%). At a mean postoperative follow-up of 44.1 months, best-corrected visual acuity improved ≥2 Snellen lines in 9 eyes (56.2%), remained stable in 6 (37.5%) and worsened in 1 eye (11.1%). Systemic medication was significatively reduced after surgery (p = .020) and macular thickness on optical coherence tomography exams decreased significatively in eyes with macular edema (p= .0039). In this small series of eyes with limited follow-up PPV seems to be a safe and effective for treatment of vitreoretinal complications in patients with BCR.